Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells

Cellular Signalling

Volumn 25, Issue 9, 2013, Pages 1780-1791

  Desai, Sejal ^a   Laskar, S ^b   Pandey, B N ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

ATF 2; Epithelial mesenchymal transition; IL 8; Invasion; JNK p38; VEGF

Indexed keywords

ACTIN; ACTIVATING TRANSCRIPTION FACTOR 2; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ACTIN FILAMENT; ANOIKIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879250983     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.05.025     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. CA: A Cancer Journal for Clinicians 2010, 60:277-300.
2. Behera D., Balamugesh T. The Indian Journal of Chest Diseases & Allied Sciences 2004, 46:269-281.
3. Chambers A.F., Groom A.C., MacDonald I.C. Nature Reviews Cancer 2002, 2:563-572.
4. Pantel K., Brakenhoff R.H. Nature Reviews Cancer 2004, 4:448-456.
5. Thiery J.P. Nature Reviews Cancer 2002, 2:442-454.
6. Hay E.D. Acta Anatomica (Basel) 1995, 154:8-20.
7. Guarino M. The International Journal of Biochemistry & Cell Biology 2007, 39:2153-2160.
8. Guarino M., Rubino B., Ballabio G. Pathology 2007, 39:305-318.
9. Wu Y., Zhou B.P. Acta Biochimica et Biophysica Sinica (Shanghai) 2008, 40:643-650.
10. Mattei S., Colombo M.P., Melani C., Silvani A., Parmiani G., Herlyn M. International Journal of Cancer 1994, 56:853-857.
11. Moradi M.M., Carson L.F., Weinberg B., Haney A.F., Twiggs L.B., Ramakrishnan S. Cancer 1993, 72:2433-2440.
12. Burke F., Relf M., Negus R., Balkwill F. Cytokine 1996, 8:578-585.
13. Hazelbag S., Fleuren G.J., Baelde J.J., Schuuring E., Kenter G.G., Gorter A. Gynecologic Oncology 2001, 83:235-243.
14. Desai S., Kumar A., Laskar S., Pandey B.N. Cytokine 2013, 61:54-62.
15. Moustakas A., Heldin C.H. Cancer Science 2007, 98:1512-1520.
16. Han G., Lu S.L., Li A.G., He W., Corless C.L., Kulesz-Martin M., Wang X.J. The Journal of Clinical Investigation 2005, 115:1714-1723.
17. Petrella B.L., Armstrong D.A., Vincenti M.P. Cancer Letters 2012, 325:220-226.
18. Huang C., Jacobson K., Schaller M.D. Journal of Cell Science 2004, 117:4619-4628.
19. Vlahopoulos S.A., Logotheti S., Mikas D., Giarika A., Gorgoulis V., Zoumpourlis V. Bioessays 2008, 30:314-327.
20. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Journal of Biological Chemistry 1995, 270:7420-7426.
21. Beier F., Taylor A.C., LuValle P. Journal of Biological Chemistry 2000, 275:12948-12953.
22. Hayakawa J., Depatie C., Ohmichi M., Mercola D. Journal of Biological Chemistry 2003, 278:20582-20592.
23. Papassava P., Gorgoulis V.G., Papaevangeliou D., Vlahopoulos S., van Dam H., Zoumpourlis V. Cancer Research 2004, 64:8573-8584.
24. Ronai Z., Yang Y.M., Fuchs S.Y., Adler V., Sardana M., Herlyn M. Oncogene 1998, 16:523-531.
25. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., Young L.S. Journal of Biological Chemistry 1999, 274:16085-16096.
26. Nakagawa H., Liyanarachchi S., Davuluri R.V., Auer H., Martin E.W., de la Chapelle A., Frankel W.L. Oncogene 2004, 23:7366-7377.
27. Pollard J.W. Nature Reviews Cancer 2004, 4:71-78.
28. Muehlberg F.L., Song Y.H., Krohn A., Pinilla S.P., Droll L.H., Leng X., Seidensticker M., Ricke J., Altman A.M., Devarajan E., Liu W., Arlinghaus R.B., Alt E.U. Carcinogenesis 2009, 30:589-597.
29. Wang Y., Xu R.C., Zhang X.L., Niu X.L., Qu Y., Li L.Z., Meng X.Y. Cytokine 2012, 59:145-155.
30. Santibanez J.F. FEBS Letters 2006, 580:5385-5391.
31. Gonzalez-Moreno O., Lecanda J., Green J.E., Segura V., Catena R., Serrano D., Calvo A. Experimental Cell Research 2010, 316:554-567.
32. Petreaca M.L., Yao M., Liu Y., Defea K., Martins-Green M. Molecular Biology of the Cell 2007, 18:5014-5023.
33. Guo C.B., Wang S., Deng C., Zhang D.L., Wang F.L., Jin X.Q. Molecular Diagnosis & Therapy 2007, 11:183-192.
34. Martin-Blanco E., Pastor-Pareja J.C., Garcia-Bellido A. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7888-7893.
35. Kaltschmidt J.A., Lawrence N., Morel V., Balayo T., Fernandez B.G., Pelissier A., Jacinto A., Martinez Arias A. Nature Cell Biology 2002, 4:937-944.
36. Huang C., Rajfur Z., Borchers C., Schaller M.D., Jacobson K. Nature 2003, 424:219-223.
37. Martin-Blanco E. Bioessays 2000, 22:637-645.
38. Hedges J.C., Dechert M.A., Yamboliev I.A., Martin J.L., Hickey E., Weber L.A., Gerthoffer W.T. Journal of Biological Chemistry 1999, 274:24211-24219.
39. Tindberg N., Porsmyr-Palmertz M., Simi A. Neurochemical Research 2000, 25:527-531.
40. Ricote M., Garcia-Tunon I., Bethencourt F., Fraile B., Onsurbe P., Paniagua R., Royuela M. The Journal of Pathology 2006, 208:401-407.
41. Song H., Ki S.H., Kim S.G., Moon A. Cancer Research 2006, 66:10487-10496.